Free Trial

Neurogene (NGNE) Short Interest Ratio & Short Volume

Neurogene logo
$9.90 -0.56 (-5.35%)
As of 11:59 AM Eastern

Neurogene Short Interest Data

Neurogene (NGNE) has a short interest of 2.18 million shares, representing 12.59% of the float (the number of shares available for trading by the public). This marks a 11.22% increase in short interest from the previous month. The short interest ratio (days to cover) is 9.3, indicating that it would take 9.3 days of the average trading volume of 240,822 shares to cover all short positions.

Current Short Interest
2,180,000 shares
Previous Short Interest
1,960,000 shares
Change Vs. Previous Month
+11.22%
Dollar Volume Sold Short
$36.41 million
Short Interest Ratio
9.3 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
14,930,000 shares
Float Size
17,310,000 shares
Short Percent of Float
12.59%
Today's Trading Volume
60,120 shares
Average Trading Volume
240,822 shares
Today's Volume Vs. Average
25%
Short Selling Neurogene?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Neurogene and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NGNE Short Interest Over Time

NGNE Days to Cover Over Time

NGNE Percentage of Float Shorted Over Time

Remove Ads

Neurogene Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20252,180,000 shares $36.41 million +11.2%12.6%9.3 $16.70
2/28/20251,960,000 shares $34.67 million +12.0%11.3%8 $17.69
2/15/20251,750,000 shares $32.24 million -12.9%10.1%5.4 $18.42
1/31/20252,010,000 shares $31.86 million +10.4%11.4%4.8 $15.85
1/15/20251,820,000 shares $33.74 million No Change10.4%4.6 $18.54
12/31/20241,820,000 shares $41.61 million +13.8%11.3%4.8 $22.86
12/15/20241,600,000 shares $37.62 million +36.8%9.9%4.3 $23.51
11/30/20241,170,000 shares $29.75 million -28.7%10.2%3.4 $25.43
11/15/20241,640,000 shares $56.60 million +79.4%14.2%5.4 $34.52
10/31/2024914,200 shares $40.23 million -2.2%8.9%6.8 $44.01
10/15/2024934,600 shares $46.70 million -50.8%9.1%8.2 $49.97
9/30/20241,900,000 shares $79.72 million +6.2%18.5%16.8 $41.96
9/15/20241,790,000 shares $75.09 million -1.7%17.4%13.7 $41.95
8/31/20241,820,000 shares $68.10 million +4.6%17.7%14.1 $37.42
8/15/20241,740,000 shares $61.98 million +11.5%16.9%13.6 $35.62
7/31/20241,560,000 shares $64.18 million +8.3%13.4%12.6 $41.14
7/15/20241,440,000 shares $66.17 million +34.6%12.4%12.4 $45.95
6/30/20241,070,000 shares $38.94 million +0.9%9.2%9.5 $36.39
6/15/20241,060,000 shares $45.15 million +8.5%9.1%10.1 $42.59
5/31/2024977,400 shares $36.75 million -2.0%8.4%7.8 $37.60
5/15/2024997,800 shares $33.52 million -2.2%8.6%7.5 $33.59
4/30/20241,020,000 shares $35.17 million +3.2%8.9%7.7 $34.48
4/15/2024988,100 shares $36.98 million +9.1%8.6%7.1 $37.43
3/31/2024906,000 shares $46.12 million +130.4%7.9%6.7 $50.90
3/15/2024393,200 shares $14.76 million +50.8%3.4%3.4 $37.53
2/29/2024260,700 shares $8.10 million +68.2%2.3%3.4 $31.07
2/15/2024155,000 shares $4.65 million +295.4%1.3%2.4 $30.00
1/31/202439,200 shares $1.18 million No Change0.4%0.8 $30.16

NGNE Short Interest - Frequently Asked Questions

What is Neurogene's current short interest?

Short interest is the volume of Neurogene shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 2,180,000 shares of NGNE short. 12.59% of Neurogene's shares are currently sold short. Learn More on Neurogene's current short interest.

What is a good short interest ratio for Neurogene?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGNE shares currently have a short interest ratio of 9.0. Learn More on Neurogene's short interest ratio.

Which institutional investors are shorting Neurogene?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Neurogene: Group One Trading LLC, Citadel Advisors LLC, Bank of America Corp DE, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Neurogene?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.59% of Neurogene's floating shares are currently sold short.

Is Neurogene's short interest increasing or decreasing?

Neurogene saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 2,180,000 shares, an increase of 11.2% from the previous total of 1,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Neurogene's float size?

Neurogene currently has issued a total of 14,930,000 shares. Some of Neurogene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neurogene currently has a public float of 17,310,000 shares.

How does Neurogene's short interest compare to its competitors?

12.59% of Neurogene's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Neurogene: Cronos Group Inc. (2.27%), Cogent Biosciences, Inc. (11.39%), Prothena Co. plc (20.66%), AbCellera Biologics Inc. (10.19%), Arbutus Biopharma Co. (5.26%), ArriVent BioPharma, Inc. (18.99%), CureVac (4.34%), ChromaDex Co. (4.29%), Trevi Therapeutics, Inc. (8.05%), Nuvation Bio Inc. (12.52%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Neurogene stock?

Short selling NGNE is an investing strategy that aims to generate trading profit from Neurogene as its price is falling. NGNE shares are trading down $0.56 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Neurogene?

A short squeeze for Neurogene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NGNE, which in turn drives the price of the stock up even further.

How often is Neurogene's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGNE, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:NGNE) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners